Neuroscience and Medicine

Volume 7, Issue 1 (March 2016)

ISSN Print: 2158-2912   ISSN Online: 2158-2947

Google-based Impact Factor: 0.67  Citations  

Determinants of Neurocognitive Impairment in HIV in a Cohort of Patients on Antiretroviral Therapy Followed in Bangui (Central African Republic)

HTML  XML Download Download as PDF (Size: 308KB)  PP. 1-9  
DOI: 10.4236/nm.2016.71001    2,811 Downloads   3,950 Views  Citations

ABSTRACT

Infection with HIV is one of the deadliest epidemics of our time and its type is widespread in the Central African Republic. It is frequently accompanied by neurological complications. Objective: To contribute to a better understanding of neurocognitive disorders in patients living with HIV (PLHIV) in Bangui, and to identify associated factors using the International HIV Dementia Scale (IHDS) as a screening tool. We conducted a descriptive and analytical cross-sectional study from 1 December 2014 to 30 January 2015, in a cohort of patients seen on one of the supported sites in Bangui. A total of 400 patients were received in follow-up visit during the study period of which 244 met the inclusion criteria. The prevalence of neurocognitive disorders was 25%, 95% CI [19.70 - 30.92]. The mean age of subjects was 42.77 ± 9.58 with extremes ranging from 24 - 64 years. The sex ratio (F/M) was 4.5 in. The average score for different tests was 10.93 ± 1.13 with extremes of 7 and 12. The disorder was more about the gestural sequence. Determinants of neurocognitive disorders in the cohort were older age and lower educational level (p < 0.05). It is useful to conduct further studies to confirm these results by combining a battery of neuropsychological tests to recommend this test for all the support sites of PLHIV in the country.

Share and Cite:

Pascal, M. , Gaspard, T. , Philomène, N. , Emmanuel, Y. , Phrygie Avilah, A. and Hortense, H. (2016) Determinants of Neurocognitive Impairment in HIV in a Cohort of Patients on Antiretroviral Therapy Followed in Bangui (Central African Republic). Neuroscience and Medicine, 7, 1-9. doi: 10.4236/nm.2016.71001.

Cited by

[1] Worldwide Occurrence of HIV-Associated Neurocognitive Disorders and Its Associated Factors: A Systematic Review and Meta-Analysis. Front
Frontiers in Psychiatry, 2022
[2] A systematic review and meta-analysis of HIV associated neurocognitive disorders (HAND) among people with HIV in Ethiopia
AIDS Research and Therapy, 2021
[3] Worldwide Prevalence of HIV Associated Neurocognitive Disorders (HAND) and its associated factors: A systematic review and meta-analysis
2021
[4] Prevalence and factors associated with neuro cognitive disorders among HIV-positive patients in Ethiopia: A hospital-based cross-sectional study
2020
[5] Prevalence of Cognitive Impairment and Its Predictors among HIV/AIDS Patients on Antiretroviral Therapy in Jimma University Medical Center, Southwest Ethiopia
2019
[6] Prevalence of cognitive impairment and its predictors among HIV/AIDS patients on antiretroviral therapy in Jimma University Medical Center, Southwest …
2019
[7] Impaired Neurocognitive and Physical Performances in Activities of Daily Living: Are Patients with WHO Stage I/II (Early) HIV Disease and High CD4+ Cell …
2018
[8] Voices from Australia–concerns about HIV associated neurocognitive disorder
AIDS Care, 2018
[9] Cognitive functions in newly diagnosed patients with HIV infection in a tertiary health facility: Assessment using community screening interview for dementia
eNeurologicalSci, 2017

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.